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Circadian Rhythms: “External Cues” 
Versus “Internal Clock”
What would happen if there was no light? What would 
control the biological rhythm of a human being or a plant? 
Jean-Jacques d’Ortous de Mairan asked this question in 
17291 when observing the movement of the leaves of a 
plant in synchrony with sunlight. He noted that a 24-hour 
pattern in the movement of the leaves of the Mimosa 
pudica plant continued even when the plant was kept in 
constant darkness. He concluded that there must be an 
“internal clock” that provided a circadian rhythm even 
without the presence of light. More than 200 years later, 
Jürgen Aschoff applied similar methods to investigations 
in humans by building an underground “bunker” to isolate 
human subjects from any external environmental cues.2 
Aschoff’s research demonstrated that humans exhibited a 
persistent 25-hour biological cycle. A similar cycle has 
been identified in studies examining the circadian rhythms 
of blind persons.3 However, it was not until researchers 
began experimenting with the circadian system in 
Drosophila melanogaster in the 1970s, that gene loci such 
as Clock or Period were identified as important regulators 
of these processes4 (Figure 1). Results demonstrated that 
when Clock or Period genes were disrupted in animals, the 
circadian rhythm was severely compromised in conditions 
of constant darkness. To emphasize the endogenous self-
sustained nature of biological rhythms, Franz Halberg 
coined the term circadian (Latin: circa = about; dies = day) 
time to refer to daily rhythms that are endogenously gener-
ated.5 As such, any biological process in the body that 
repeats itself over a period of approximately 24 hours and 
maintains this rhythm in the absence of external stimuli is 
termed a circadian rhythm.
In contrast, the term zeitgeber (German for “time giver” 
or “synchronizer”) was first used by Jürgen Aschoff to 
emphasize the existence of exogenous (external) cues that 
influence the timing of these internal clocks.6 To maintain 
circadian synchrony, “zeitgebers” induce changes in the 
concentrations of the molecular components of the clock to 
levels consistent with the appropriate stage in the 24-hour 
cycle, a process termed entrainment (Figure 1). Thus, circa-
dian entrainment describes a biological rhythm that is syn-
chronized with the external physical environment. The 
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most dominant zeitgeber appears to be sunlight, not sur-
prising, as it is the strongest and most dependable represen-
tation of the time of day.7,8
As such, a hallmark of the mammalian circadian pace-
maker—located in the suprachiasmatic nuclei (SCN) 
within our brain—is its ability to be synchronized by light, 
thus allowing organisms to adapt to temporal variations in 
natural light conditions.9 Photic stimuli are transmitted 
from the retina to target neurons in the brain, where they 
are transduced to the molecular clockwork.10,11 Light acti-
vation of melanopsin receptors11 in the retinal ganglion 
cells leads to the transcriptional induction of circadian 
rhythm proteins (such as Clock, Bmal1, Rev-Erb, Period 
1, Period 2, Cryptochrome 1, and Cryptochrome 2) and 
concomitant synchronization. Peripheral tissues display 
oscillations in circadian rhythm protein expression similar 
to those of the brain,12,13 likely through secreted signaling 
molecules (Figure 1).10,14,15
Although it is now accepted that a component of our 
genome reflects the evolutionary influence of the earth’s 
daily rotation about its axis,16 little is known about how 
disturbances in this circadian system affect patient health 
and clinical outcomes. Further basic and clinical research 
addressing the importance of circadian rhythms in the con-
text of critical care and anesthesia is highly warranted and 
necessary to develop a better understanding of complex 
pathophysiology and novel diagnostic and therapeutic 
approaches.
The Biology of Light
Earth’s 24-hour rotational cycle with its light and dark peri-
ods has existed for more than 4 billion years and has led to 
the evolution of circadian rhythms in most organisms. 
Studies in numerous species have demonstrated that day-
light is a powerful synchronizer that resets, in an intensity-
dependent manner, endogenous circadian pacemakers.17-21
One of the most remarkable and measurable biological 
effects of light is suppression of melatonin production.22 In 
1980, a study demonstrated that bright light, both sunlight 
and intense artificial light, could suppress melatonin pro-
duction in humans.23 This research confirmed that humans 
have biological rhythms cued by sunlight and further, sug-
gested that bright artificial light could be substituted for 
sunlight in order to experimentally, and perhaps therapeu-
tically, manipulate biological rhythms in humans.
Sunlight has an intensity of greater than 10 000 lux, 
while ordinary room light is approximately 200 lux. It is 
compelling that light of different intensities appears to 
have different effects on the human body. With the excep-
tion of a few micro-environments, life on earth has adapted 
to a consistent pattern of alternating light-dark cycles. This 
was true for most of human evolution as well, until the 
widespread adoption of artificial lighting approximately 
150 years ago. Beyond affecting circadian rhythms, recent 
evidence suggests that exposure to unnatural light cycles 
increases the risk for cancer,24 sleep disturbances,25 and 
mood disorders.26 Furthermore, exposure to nighttime 
light has been linked to changes in metabolism. Shift 
workers who experience sustained nighttime illumination 
are at increased risk for cardiovascular disease and ele-
vated body mass index27-30 and nighttime light exposure at 
home is associated with increased body mass, waist cir-
cumference, elevated triglyceride levels, and poor choles-
terol balance.31
Impact of Circadian Rhythms on 
Specific Clinical Disorders
While the analysis of circadian rhythm proteins and their 
misalignment in humans is difficult to assess, melatonin 
levels seem to be an excellent surrogate for a “normal” 
circadian rhythm.32 As such sleep restriction has been 
shown to affect melatonin levels and circadian rhythms in 
humans.32 On a molecular level, a mutation of the human 
circadian rhythm protein Per2 leads to a sleep disorder that 
is known as “familial advanced sleep-phase syndrome.”33 
Interestingly, to identify somebody with this disease, 
early-morning serum melatonin levels are widely used and 
validated.34
Recent research has revealed that sleep duration has 
decreased in the United States.35 Simultaneously, the prev-
alence of metabolic disease has increased over the same 
Figure 1. Regulatory mechanisms of the circadian system: 
The suprachiasmatic nucleus (SCN) in the brain is the central 
regulator of circadian rhythmicity. External stimuli such as light 
determine “zeitgeber” time. Light via melanopsin receptors in 
the retinal ganglion cells lead to the transcriptional induction 
of Clock and Bmal1, which leads in turn to the induction of 
Rev-Erb, Per1, Per2, Cry1, and Cry2. Via feedback inhibition 
of Clock and Bmal1, a cycle will be terminated and a new can 
begin. Hormonal and humoral factors are supposed to control 
circadian rhythms in peripheral organs.
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time period.35 Numerous cross-sectional and prospective 
clinical studies have demonstrated that shorter duration and 
poor-quality sleep predicts the development of obesity and 
type 2 diabetes, even after age, body mass index, and 
various other confounding variables are taken into 
account.32,36-41 In one study, sleep restriction to 4 hours for 
6 consecutive nights led to an impaired insulin sensitivity 
in a glucose challenge test.42 These observations argue for 
the involvement of circadian rhythms in the pathogenesis 
of diseases, including diabetes and obesity. However, spe-
cific knowledge of circadian rhythm proteins and their 
molecular mechanisms will be required to prove causality.
Disruption of circadian rhythms may also play a role in 
a variety of central nervous system disorders. Examples 
include not only the aforementioned sleep disorders 
(delayed or advanced sleep phase disorder33,43) but also 
bipolar affective disorders.44 Specific genetic variations in 
circadian clock genes have been identified for bipolar dis-
ease and schizophrenia,45 and genetic polymorphisms in 
several clock genes have been linked to sleep disorders.46
In addition to central nervous system disorders, epide-
miological studies have demonstrated that late-shift and 
overnight workers have a higher incidence of cardiovascu-
lar disease.27,47-52 Evidence of an association between dis-
rupted circadian rhythms and cardiovascular disease has 
been established in research on blood pressure,53 heart 
rate,54 endothelial function,55 and the onset of myocardial 
infarction and stroke.55,56 These clinical conditions all 
have distinct circadian patterns and disruption of biologi-
cal rhythms may in particular contribute to the develop-
ment of cardiovascular disease.57 Other clinical diseases, 
including cancer, diabetes, and metabolic syndrome have 
also been associated with disrupted circadian rhythms.36-40
Unfortunately, genetic studies on circadian rhythm pro-
teins in relation to those specific diseases are rare. A few 
polymorphisms of clock genes have been found in humans 
that are associated with metabolic diseases. For example, 
polymorphisms in Clock and Bmal1, have been linked to 
features of the metabolic syndrome. In small sample popu-
lations, polymorphisms in the Clock gene have been cor-
related with predisposition to obesity,58,59 and 2 Bmal1 
haplotypes are associated with type 2 diabetes and hyper-
tension.60 Polymorphisms within other clock core genes 
(ie, Per2) have been associated with hypertension and high 
fasting blood glucose in studies of similar sample size.61
Recently, several genome-wide association studies led 
to the unexpected discovery that melatonin, a hormone 
implicated in seasonal and circadian rhythms, may be 
important in the regulation of mammalian glucose lev-
els.62,63 Indeed, genetic variants of the melatonin 1B recep-
tor gene (MTNR1B) increase type 2 diabetes risk. In line 
with their role in type 2 diabetes, MTNR1B is expressed in 
pancreas cells, and melatonin modulates glucose-stimu-
lated insulin secretion.64 Interestingly, melatonin secretion 
is reported to be impaired in type 2 diabetic patients65 and 
the melatonin profile relative to the feeding/fasting cycle 
is reversed when individuals are subjected to forced dys-
synchrony.66 These findings raise the possibility that dis-
ruption of circadian systems, either directly at the level of 
altered clock gene expression, or indirectly through effects 
on melatonin, may contribute to human metabolic syn-
drome and cardiovascular disease.
Novel Molecular Mechanisms
The organ-specific role of circadian rhythm proteins in the 
development of clinical disease has been an area of intense 
research over the past few years and significant advances 
in this field have recently been achieved. When specific 
circadian rhythm proteins are absent in mice, these ani-
mals develop similar medical conditions to those described 
in late-shift workers or patients with presumably disrupted 
circadian rhythms (Figure 2).
The Clock protein represents an important pacemaker 
of the circadian network acting in the SCN (Figure 1). 
When the Clock gene is deleted in mice, these animals 
develop “late-shift diseases,” including diabetes15 and car-
diovascular disorders.67 Clock even directly influences the 
endocrine function of the pancreas. When Clock is specifi-
cally deleted from the pancreas, mice are unable to secrete 
insulin and develop type 1 diabetes (Figure 2).68
Cryptochromes are another group of proteins known to 
play a role in circadian rhythms and have also been linked 
to the development of disease. Cryptochrome deficient 
mice exhibit enhanced aldosterone production leading to 
arterial hypertension69 as well as disrupted regulation of 
hepatic gluconeogenesis and insulin resistance (Figure 2).70
Acute myocardial infarction is one of the most well-
documented acute disease states with a diurnal or circa-
dian incidence.71-73 Investigations into the molecular 
mechanism of this clinical observation linked the circadian 
rhythm protein Per2 to myocardial ischemia.13,15,71,74 In a 
mouse model of myocardial infarction, infarct sizes exhib-
ited a circadian pattern. Furthermore, Per2 deficiency 
increased the size of myocardial infarcts. In contrast, when 
Per2 was overexpressed by intense daylight exposure, the 
size of the necrotic area after myocardial infarction was 
significantly reduced.13 This study also reported elevated 
Per2 levels in human heart tissue of patients suffering from 
ischemic heart failure (Figure 2).13
Further studies have linked Per2 to noncardiac periph-
eral ischemia. Lack of the Per2 protein was injurious in a 
murine model for hind limb ischemia, leading to autoam-
putation of the affected legs.75 In addition, Per2 seems to 
be involved in modulating the inflammatory response to 
tissue ischemia.71 Together, these findings indicate an 
important role for the circadian system, and in particular 
the Per2 protein, in tissue ischemia.
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Sudden cardiac arrest, often a consequence of cardiac 
arrhythmias, also exhibits a circadian pattern. A recent 
study identified a transcription factor, krueppel-like factor 
15 (Klf15), as an important regulator of cardiac potassium 
channels.76 Klf15 was shown to be transcriptionally under 
the control of the circadian rhythm proteins. Disruption of 
certain circadian rhythm proteins (Bmal1 or Per2) resulted 
in marked action potential prolongation due to near com-
plete elimination of the fast component of the transient 
outward potassium current. As a result, deficiency or 
excess of Klf15 caused loss of rhythmic QT variation, 
abnormal repolarization, and enhanced susceptibility to 
ventricular arrhythmias. These findings point to circadian 
transcription of ion channels as a mechanism for cardiac 
arrhythmogenesis (Figure 2).
Finally, several recent studies found an association 
between circadian rhythms and the immune system. In 
particular, Toll-like receptors (TLRs) seemed to be sub-
stantially regulated in a circadian pattern. TLRs are a 
class of proteins that play a key role in innate and adap-
tive immunity and have been implicated in several dis-
eases, including sepsis, various immunodeficiencies, 
atherosclerosis, asthma, and myocardial ischemia.77 In 
this recent study, TLR9 exhibits circadian regulation in 
mice. This means that the inflammatory response to 
severe infection, as occurs in sepsis, is likely oscillating 
in a circadian fashion.78 Other studies have demonstrated 
that the transcription factor Rev-Erb (Figure 1), an impor-
tant regulator of the circadian network, also influences 
the synthesis and secretion of interleukin-17 (IL-17) 
from T helper cells.79 IL-17 producing T helper cells are 
pro-inflammatory immune cells and circadian disruption 
has been associated with elevated intestinal T(H)17 cell 
frequencies and increased susceptibility to inflammatory 
disease (Figure 2).79
Taken together, this group of recently published studies 
indicates a very important role for the circadian rhythm 
network and its regulation in the development and pro-
gression of various diseases, including diabetes, hyperten-
sion, heart disease and sepsis. More specifically, this work 
has begun to describe the precise functions of the circadian 
proteins in peripheral organs and the mechanisms by 
which they may contribute to many important human dis-
eases. Further clinical studies in humans are needed to 
apply this emerging knowledge to novel diagnostic and 
therapeutic strategies.
Implications for Clinical Practice
An improved understanding of the association between 
circadian rhythms and specific disease states could lead 
to significant changes in clinical practice and patient 
Figure 2. Disruption of the molecular “clock” and disease development. Numerous recent studies provide evidence that the 
circadian clock influences the development and progression of disease in an experimental setting. Nonfunctional circadian rhythm 
proteins in peripheral organs were linked to very specific disease (eg, Clock-diabetes, Cryptochrome-hypertension, Per2-heart 
attack, etc). These findings indicate that time-of-day–dependent drug therapy or interventions might be imperative. However, more 
important seems to be the restoration of circadian rhythms to improve the function of circadian rhythm pathways such as insulin 
secretion, inflammation, or metabolism.
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outcomes (Figure 2). Timing of therapeutic interventions, 
ranging from medication delivery to major surgery,80,81 
may be altered based on comprehension of these biologi-
cal systems. Research in chronotherapeutics82 has already 
demonstrated promising results by improving the thera-
peutic index of several drugs. Chronotherapeutics 
involves synchronizing drug administration with a 
patient’s daily, monthly, seasonal, or yearly biological 
clock, in order to maximize the health benefits and mini-
mize adverse effects. For example, as a result of circa-
dian variations in cholesterol synthesis (via the diurnal 
rhythmicity of the rate limiting enzyme HMG-CoA 
reductase) the efficacy of cholesterol-lowering statin 
medications is improved when these drugs are taken at 
bedtime. One of the first wide-scale applications of chro-
notherapeutics took place in the 1960s and involved syn-
thetic corticosteroids.83 However, the results did not 
necessarily translate into major changes in clinical prac-
tice and where changes did occur, they were not always 
recognized as chronotherapeutics.84,85
Recent studies on blood pressure medication made 
clear that bedtime administration is more effective than 
administration during morning hours. In addition, reduc-
tion in blood pressure during sleep has been identified as 
the most significant predictor of decreased cardiovascular 
risk in patients. As such, patients with chronic kidney dis-
ease have a high prevalence of increased blood pressure 
during sleep and a blunted sleep time–related blood pres-
sure decline (a “nondipper” pattern), which is associated 
with disease severity. Administration of blood pressure 
lowering drugs at bedtime could therefore lead to signifi-
cant improvement is this clinical setting.80,86
Inpatient insulin dosing may be optimized by incorpo-
rating recent evidence that supports a circadian pattern to 
insulin secretion and insulin sensitivity87. Further studies 
are required to determine the appropriate dosing and glu-
cose level associated with best outcomes given the known 
dysfunction in the circadian system associated with critical 
illness.88 Similarly, the improved clinical outcomes associ-
ated with intermittent versus continuous tube feeding may 
ultimately be explained by circadian patterns of hepatic 
metabolism.89
Circadian variation in immune system function may 
have broad impact in infectious disease states including 
sepsis and septic shock. The use of corticosteroids 
remains a common, albeit controversial, adjunct therapy 
for septic shock.90 Sepsis has been shown to be associ-
ated with elevated serum concentrations of IL-17, which 
can in turn be dampened by treatment with hydrocorti-
sone.91 Given the nature of circadian rhythms and a 
recently described regulation of IL-17 by the circadian 
clock,79 it is possible that the efficacy of corticosteroids 
in the management of sepsis could be greatly enhanced 
by synchronizing administration with these rhythms. 
Moreover, the clinical chronotherapy of corticosteroids 
might not only improve desired effects but, at the same 
time, avoid or minimize their side effects.
While some therapies, including anticoagulants, might 
already be administered at the correct time of day (we 
know, for example that in the early morning hours coagu-
lation is enhanced) it remains unclear if these therapies are 
also effective when the normal circadian system has been 
disrupted. Successful pharmacotherapy may necessitate 
moving beyond identifying the optimal time of day for 
administration of a given drug (Figure 2). Indeed, restora-
tion of a nonfunctional circadian system might be required 
before a treatment can be most effective. Daylight (and 
“real” night) simulation in intensive care units or novel 
drugs that could resynchronize the circadian system (Rev-
Erb-agonists92) hold promise as emerging therapies to 
restore circadian function.
Circadian Rhythms in Anesthesia
Analgesics, including narcotics and various local anesthet-
ics, are used on a daily basis by anesthesiologists. Early 
researchers discovered a time of day dependency for mor-
phine-induced analgesia and duration of action for local 
anesthetics.93-95
Interestingly, recent reports support a strong association 
between surgery under general anesthesia and disturbances 
in circadian rhythms. It is proposed that these disturbances 
may lead to postoperative sleep and cognitive disorders.96-98 
Specific medications used during general anesthesia are 
thought to play a role in these circadian disruptions. 
Clinically, many patients experience profound sleep disrup-
tion and delirium following surgery and general anesthesia. 
Managing this effect has the potential to help expedite post-
operative recovery and improve postoperative cognitive 
function. Restoration or resetting of the circadian rhythm 
following general anesthesia might help to blunt or alleviate 
symptoms of insomnia, confusion, and postoperative delir-
ium. The prevention of postoperative delirium is crucially 
important given the strong association between postopera-
tive delirium and increased morbidity and mortality.99-104
Circadian Rhythms in Critical Care 
Medicine
Effects on Sleep and Cognitive Function
Critically ill patients suffer from similar disruption in circa-
dian rhythms and the clinical effects of altered sleep–wake 
cycles and cognitive dysfunction.105-109 Medications used in 
the care of critically ill patients overlap and have similar 
pharmacology with those used in general anesthesia and 
thus the clinical effects of altered sleep–wake cycles and 
cognitive function are similar. Sedative medications used by 
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critical care practitioners in the treatment of agitation, delir-
ium, and insomnia likely lead to worsening of these disor-
ders.110-112 Benzodiazepines appear to be one of the worst 
offenders and thus many experts advocate for discontinuing 
their use in critically ill patients.112-115 Unfortunately, almost 
all sedative agents are associated with delirium and appear 
to worsen sleep quality.110,111,116 Dexmedetomidine may be 
associated with the least risk of developing delirium.117-120
As discussed earlier, endogenous melatonin might play 
an important role in the development of circadian rhythms 
associated diseases.62,63 Critically ill patients tend toward 
not only altered sleep patterns but also abnormal levels of 
melatonin. Results on melatonin expression have gener-
ated interest in the use of exogenous melatonin and mela-
tonin agonists to improve sleep and cognitive function.104,121 
Earlier this year, a promising randomized controlled trial 
demonstrated effectiveness in the use of a melatonin ago-
nist (Ramelteon) versus placebo in the prevention of delir-
ium.121 In the context of a possible melatonin–circadian 
rhythm–clinical disease axis, studies on endogenous and 
exogenous melatonin, pharmacological agonists, and asso-
ciated genetics could provide important insight into the 
development and treatment of critical illness.
In general, the hypothalamic–pituitary–adrenal (HPA) 
axis is also under the control of the circadian rhythm and 
plays an important role in critical illness and sleep–wake 
patterns.122,123 A prospective, observational study involv-
ing 24 critically ill sedated patients demonstrated the 
24-hour profiles of blood melatonin or cortisol were 
greatly disturbed or even abolished compared with the 
well-known rhythmic 24-hour patterns in healthy control 
subjects.124 Currently, there are gaps in our understanding 
of secretory patterns and control of cortisol during illness, 
and these gaps limit our ability to design optimal therapeu-
tic regimens.123
Finally, environmental factors play a substantial role in 
the disruption of sleep–wake cycles. Critically ill patients 
in the intensive care unit suffer from more frequent sleep 
deprivation and sleep disturbances than patients on a gen-
eral ward.105,106,125 Several factors can contribute to the 
increase in altered sleep–wake cycles, including noise, 
patient care interactions, mechanical ventilation, pain, arti-
ficial light, fatigue, stress, delirium, and other cognitive 
dysfunction.126,127 These same factors likely contribute to 
the increased risk of developing severe circadian rhythm 
disruptions (Figure 3). Clinical research on these circadian 
disruptions and the potential benefits of interventions to 
maintain normal sleep–wake cycles is needed.
Effects on Sepsis and Disease Progression
Critically ill patients, and in particular patients diagnosed 
with sepsis, have been shown to exhibit a very distinct met-
abolic phenotype.128 These patients experience dysfunction 
in mitochondria, endothelia, NO synthesis, and pyruvate 
dehydrogenase.128 Previous studies have established that 
the above defects are all associated with a dysfunction of 
the circadian rhythm protein Per2 (Figure 4).13,71,75 Two 
recent clinical trials demonstrate disrupted circadian sys-
tem function in patients with severe sepsis as demonstrated 
by urinary 6-sulfatoxy-melatonin production.129,130 This 
dysfunction was not observed in critically ill patients with-
out sepsis.129 In a rat model of sepsis, survival improved in 
animals maintained on a circadian light–dark cycle.131 
Thus, restoration of a circadian rhythm with normal Per2 
levels could be beneficial in restoring the metabolic disrup-
tion associated with sepsis (Figure 4).
Therapy
General Considerations
Restoration of an intact circadian system is likely complex 
given the multifaceted etiology for these disruptions. 
Genetic factors (polymorphisms in core clock genes), 
medications (anesthetics, benzodiazepines), and environ-
mental factors (noise, artificial lighting) can all result in 
disruption of the circadian system. Biologically, circadian 
rhythms are controlled by a cyclical expression of circa-
dian genes. Mutations in these genes could result in a mod-
ification or disruption of the circadian oscillator and 
therefore it is important to analyze genetic factors that may 
contribute to circadian disruption.132 The discovery of 
novel genes involved in circadian rhythm-related diseases 
Figure 3. Factors influencing the circadian system. While 
regular day/night cycles with dark, quiet nights are supposed to 
be the basis of a well-synchronized circadian rhythm in humans, 
noise, interventions, artificial light, and drugs on intensive care 
units have proven to disrupt a functional circadian system and 
might lead to disease progression.
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will open up new opportunities for therapy and may iden-
tify biomarkers for detection and prognosis (Figure 5).
Avoidance of offending medications and improving 
environmental conditions may prevent circadian disrup-
tions and increase the native ability of the body to maintain 
or restore an intact circadian system. Clinical outcome 
research is warranted to test this hypothesis. Studies in 
intensive care unit and non–intensive care unit patients 
have demonstrated a decreased incidence in delirium and 
improved sleep–wake cycles with nonpharmacological 
and environmental treatments.133,134 Treatments may be 
very simple and cost-effective, including earplugs and eye 
masks135-137 and early mobilization.138,139 Future trials will 
help clinicians navigate the risks and benefits of interven-
tions that may disrupt sleep and circadian function and 
develop guidelines for most effective patient care.
Beyond prevention of circadian disruption, it may be 
that enhancement of normal circadian rhythmicity has a 
role to play in disease states like sepsis. Recent efforts led 
to the discovery of specific enhancers of the circadian 
rhythm proteins. Compounds such as a “Rev-Erb” ago-
nist92 were shown to enhance the amplitude of circadian 
rhythmicity and—even more important—were able to 
improve metabolism in mice.92,140 In addition to restoration 
of circadian cycles, these medications may become promis-
ing drugs in the treatment of diabetes, myocardial ischemia, 
sepsis, and other circadian associated illnesses (Figure 6).
Light Therapy
Given the primary importance of light in the control of cir-
cadian rhythms,7,8 it can be postulated that exposure to light 
might be preventative or therapeutic in the treatment of cir-
cadian related illnesses. Regular room light is not as effec-
tive as sunlight in entraining the circadian oscillator because 
of its significantly lower intensity,23,141 and even if timed 
appropriately, may result in chronic circadian misalign-
ment.141 Evidence demonstrates an association between 
artificial indoor lighting and a deregulation of hormonal 
rhythms.142 Although studies from our group indicated day-
light exposure in animals increased the expression of Per2 
in the heart, ultimately resulting in cardioprotection, the 
exact timing and intensity of this exposure is unclear. 
Studies in animals have shown that either constant dark-
ness or constant light were worse in an animal model for 
sepsis when compared with regular day–night cycles.131 
These results underline the potential importance of main-
taining natural day–night cycles in humans. Many inten-
sive care units in the United States and Europe have been 
rebuilt to increase exposure to natural light and some new 
intensive care units in Germany (Heart Center or ICU 
Charite, Berlin, Germany) have incorporated advanced 
noise reduction and daylight simulation. Further clinical 
trials on the use of natural or artificial light to prevent or 
treat circadian-related illness are needed (Figure 6). These 
studies will have to define the length (12 vs 16 hours) of 
daylight, the wavelength (blue light vs full spectrum light), 
and the light intensity (4000 vs 14 000 lux) that might be 
beneficial in treating illness. Finally, it remains to be seen 
whether such treatments will be able to prevent or restore a 
dysfunctional circadian rhythm network.
Figure 4. The link between critical illness and the circadian 
system. Sepsis can lead to disrupted mitochondrial function, 
nonfunctional NO synthesis and deficient glycolytic pathways. 
Period 2 (Per2) deficiency has been associated with such 
metabolic alterations in mice. Therefore, one could 
hypothesize that restoration of a circadian rhythm with a 
functional Per2 protein might help restore a nonfunctional 
metabolic phenotype in sepsis and thereby alleviating illness and 
disease progression.
Figure 5. Model of disease development. Several 
environmental and genetic factors can cause disruption of 
the circadian rhythms. This disruption could contribute 
to multifactorial disease such as cardiovascular disease, a 
metabolic syndrome, or progression of critical illness.
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Summary
The circadian system influences multiple human biochemi-
cal and physiological variables, including sleep–wake 
cycles, body temperature, hormone secretion, metabolism, 
and our immune system. Recent improvements in our 
understanding of how circadian rhythms impact important 
human disease states may enable the discovery of novel 
therapies for critically ill patients or those undergoing gen-
eral anesthesia. Future research will need to include genetic 
data, as well as pharmacological and environmental factors 
in the maintenance and restoration of human circadian 
rhythms. Understanding the influence of disrupted circa-
dian rhythms on outcomes in critical care and anesthesia 
and researching new therapeutic interventions might sig-
nificantly improve the care we provide our patients.
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